DC
SLXP

Deere & Company’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Deere & Company’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-15,373
Closed -$1.59M – 1109
2014
Q1 		$1.59M Sell
15,373
-2,104
-12% -$215K 0.09% 231
2013
Q4 		$1.57M Sell
17,477
-3,736
-18% -$298K 0.08% 251
2013
Q3 		$1.42M Sell
21,213
-3,057
-13% -$211K 0.08% 254
2013
Q2 		$1.6M Buy
+24,270
New +$1.39M 0.1% 203

Other funds holding SLXP

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Deere & Company's SLXP Position: Q2 2014 in Review

Deere & Company sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2014, closing a stake of 15,373 shares — an estimated $1.59M sold.

Deere & Company first reported a position in SLXP in Q2 2013 and held it in 4 quarters. The position peaked at $1.6M in Q2 2013. 308 funds tracked by Wall St. Rank hold SLXP as of Q2 2014.

  • Deere & Company reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2014 after selling out during the quarter.
  • Deere & Company sold 15,373 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2014, an estimated $1.59M.
  • Deere & Company first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 4 quarters.
  • Deere & Company's SALIX PHARMACEUTICALS LTD DEL position peaked at $1.6M in Q2 2013.
  • 308 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2014.

Based on Deere & Company's 13F filing for Q2 2014, filed 11 Aug 2014.